Indeed, testosterone treatment at supraphysiologic levels has been shown to decrease PSA levels in some advanced CR-PCa patients and it is possible that decreased expression of ARVs could be responsible for these responses [72]. The gene discussed is KLK3; the disease is posterior cortical atrophy.